- Home
- OGC vs DNTH Comparison
OGC vs DNTH Comparison
Compare OGC & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$110.47
Company Overview
Basic Information| Metric | OGC | DNTH |
|---|---|---|
| Founded | N/A | 2015 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.5B |
| IPO Year | 2010 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OGC | DNTH |
|---|---|---|
| Price | $31.05 | $110.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $121.00 |
| AVG Volume (30 Days) | 436.9K | ★ 702.0K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,036,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.90 | $22.81 |
| 52 Week High | $31.90 | $117.88 |
Technical Indicators
Market Signals| Indicator | OGC | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 57.36 |
| Support Level | $27.40 | $79.27 |
| Resistance Level | N/A | $114.55 |
| Average True Range (ATR) | 1.01 | 5.08 |
| MACD | 0.31 | -0.59 |
| Stochastic Oscillator | 83.55 | 68.15 |
Price Performance
Historical Comparison OGC
DNTH
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.